Cargando…

Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study

AIMS: Intensification of type 2 diabetes (T2DM) treatment with GLP‐1 receptor agonists (GLP‐1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP‐1RA treatment. MATERIALS AND METHODS: We retrospectively analysed the time cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Petroni, Maria Letizia, Montesi, Luca, Colosimo, Santo, Caletti, Maria Turchese, Mazzotti, Arianna, Marchesini, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775466/
https://www.ncbi.nlm.nih.gov/pubmed/31592154
http://dx.doi.org/10.1002/edm2.82
_version_ 1783456256764149760
author Petroni, Maria Letizia
Montesi, Luca
Colosimo, Santo
Caletti, Maria Turchese
Mazzotti, Arianna
Marchesini, Giulio
author_facet Petroni, Maria Letizia
Montesi, Luca
Colosimo, Santo
Caletti, Maria Turchese
Mazzotti, Arianna
Marchesini, Giulio
author_sort Petroni, Maria Letizia
collection PubMed
description AIMS: Intensification of type 2 diabetes (T2DM) treatment with GLP‐1 receptor agonists (GLP‐1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP‐1RA treatment. MATERIALS AND METHODS: We retrospectively analysed the time course of 328 individuals with T2DM starting GLP‐1RA treatment because of insufficient metabolic control. In 29, a structured programme of elementary nutritional counselling was also implemented (elementary nutritional education [ENE]‐5 group sessions), whereas 53 entered a programme of cognitive‐behavioural treatment (CBT‐12 group sessions). Both programmes were completed within 6 months of switching to GLP‐1RAs. Data of body weight and metabolic control were followed up to 2 years as part of regular follow‐up. Weight loss targets (≥10% and ≥5%) and metabolic target (HbA1c < 7%) were analysed by Cox regression model in comparison with standard care (SC, N = 244). RESULTS: Body weight remarkably decreased following both behavioural programmes, with significant differences compared with SC at 2 years (CBT, 8.5 ± 5.9% vs 6.3 ± 6.9 in ENE and only 3.1 ± 5.7 in SC; P < 0.001 and P = 0.045 vs CBT and ENE, respectively). The 10% weight loss was achieved and maintained in approximately 30% of cases during follow‐up, and an additional 35% of cases lost between 5% and 10%. Data were consistent between behavioural programmes, after adjustment for confounders, including initial body weight (logreg Mantel‐Cox: ENE vs SC, P < 0.01; CBT vs SC, P < 0.001). No differences in metabolic control were detected between groups. CONCLUSIONS: Initiation of GLP‐1RA treatment provides an opportunity for addressing patients' needs of weight control. By producing initial weight loss, patients' motivation and self‐efficacy are expected to increase and adherence to long‐term lifestyle changes might be more easily attained.
format Online
Article
Text
id pubmed-6775466
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67754662019-10-07 Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study Petroni, Maria Letizia Montesi, Luca Colosimo, Santo Caletti, Maria Turchese Mazzotti, Arianna Marchesini, Giulio Endocrinol Diabetes Metab Original Articles AIMS: Intensification of type 2 diabetes (T2DM) treatment with GLP‐1 receptor agonists (GLP‐1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP‐1RA treatment. MATERIALS AND METHODS: We retrospectively analysed the time course of 328 individuals with T2DM starting GLP‐1RA treatment because of insufficient metabolic control. In 29, a structured programme of elementary nutritional counselling was also implemented (elementary nutritional education [ENE]‐5 group sessions), whereas 53 entered a programme of cognitive‐behavioural treatment (CBT‐12 group sessions). Both programmes were completed within 6 months of switching to GLP‐1RAs. Data of body weight and metabolic control were followed up to 2 years as part of regular follow‐up. Weight loss targets (≥10% and ≥5%) and metabolic target (HbA1c < 7%) were analysed by Cox regression model in comparison with standard care (SC, N = 244). RESULTS: Body weight remarkably decreased following both behavioural programmes, with significant differences compared with SC at 2 years (CBT, 8.5 ± 5.9% vs 6.3 ± 6.9 in ENE and only 3.1 ± 5.7 in SC; P < 0.001 and P = 0.045 vs CBT and ENE, respectively). The 10% weight loss was achieved and maintained in approximately 30% of cases during follow‐up, and an additional 35% of cases lost between 5% and 10%. Data were consistent between behavioural programmes, after adjustment for confounders, including initial body weight (logreg Mantel‐Cox: ENE vs SC, P < 0.01; CBT vs SC, P < 0.001). No differences in metabolic control were detected between groups. CONCLUSIONS: Initiation of GLP‐1RA treatment provides an opportunity for addressing patients' needs of weight control. By producing initial weight loss, patients' motivation and self‐efficacy are expected to increase and adherence to long‐term lifestyle changes might be more easily attained. John Wiley and Sons Inc. 2019-07-26 /pmc/articles/PMC6775466/ /pubmed/31592154 http://dx.doi.org/10.1002/edm2.82 Text en © 2019 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Petroni, Maria Letizia
Montesi, Luca
Colosimo, Santo
Caletti, Maria Turchese
Mazzotti, Arianna
Marchesini, Giulio
Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title_full Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title_fullStr Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title_full_unstemmed Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title_short Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
title_sort combination of glp‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: a retrospective cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775466/
https://www.ncbi.nlm.nih.gov/pubmed/31592154
http://dx.doi.org/10.1002/edm2.82
work_keys_str_mv AT petronimarialetizia combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy
AT montesiluca combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy
AT colosimosanto combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy
AT calettimariaturchese combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy
AT mazzottiarianna combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy
AT marchesinigiulio combinationofglp1receptoragonistsandbehaviouraltreatmentintype2diabeteselicitssynergisticeffectsonbodyweightaretrospectivecohortstudy